Publications by authors named "Alejandro Forner"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

29,070

Total Likes

699

Extended Reach

732,850

Social Features

78
B
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Maria Reig, Alejandro Forner, Jordi Rimola, Joana Ferrer-Fàbrega, Marta Burrel, Ángeles Garcia-Criado, Robin K Kelley, Peter R Galle, Vincenzo Mazzaferro, Riad Salem

J Hepatol· March 2022

Videos about Article: user user user

3 6 75 5

View All Article and Social Media Activity
C
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.
Jesus M Banales, Pedro M Rodrigues, Silvia Affò, Jesper B Andersen, Patricia Aspichueta, Alejandro Forner

Nat Rev Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update.
Maria Reig, Marco Sanduzzi-Zamparelli, Alejandro Forner, Jordi Rimola, Joana Ferrer-Fàbrega

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients.
Belén Saborido, Anna Darnell, Alejandro Forner, Ángeles García-Criado, Alba Díaz

Eur Radiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170].
Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, Julien Edeline, Mairéad G McNamara, Alejandro Forner

Lancet Reg Health Eur· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.
Carla Fuster-Anglada, Josep Corominas, Aida Marsal, Neus Llarch, Gemma Iserte, Alejandro Forner

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma.
Ezequiel Mauro, Manuel Rodríguez-Perálvarez, Antonio D'Alessio, Gonzalo Crespo, Federico Piñero, Alejandro Forner

Liver Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT).
Jose M Miro, Daniela Malano-Barletta, Leire Berrocal, Christian Manzardo, Anna Castelli, Alejandro Forner

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe.
Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, Julien Edeline, Mairéad G McNamara, Alejandro Forner

Lancet Reg Health Eur· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk.
Núria Granel, Gemma Iserte, Concepció Bartres, Neus Llarch, Anna Pla, Alejandro Forner

BMC Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection.
Carla Fuster-Anglada, Ezequiel Mauro, Joana Ferrer-Fàbrega, Berta Caballol, Marco Sanduzzi-Zamparelli, Alejandro Forner

J Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study.
Arunkumar Krishnan, Carolin V Schneider, Hendrik-Tobias Arkenau, Ezequiel Matias Mauro, Alejandro Forner

J Clin Transl Endocrinol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: Addressing oncological surveillance in gender-affirming care for transgender and gender diverse liver transplant patients.
Trinidad Labanca, Gonzalo Crespo, Alejandro Forner, Ivan Mañero, Ezequiel Mauro

Am J Transplant· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing a domain-specific large language model for LI-RADS v2018 categorization of free-text MRI reports: a feasibility study.
Mario Matute-González, Anna Darnell, Marc Comas-Cufí, Javier Pazó, Alexandre Soler, Alejandro Forner

Insights Imaging· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence and choice: The BCLC vision for tailoring clinical decision-making.
Maria Reig, Alejandro Forner, Jordi Rimola, Joana Ferrer-Fàbrega, Marta Burrel

J Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies.
Ezequiel Mauro, Marco Sanduzzi-Zamparelli, Gabrielle Jutras, Raquel Garcia, Alexandre Soler Perromat, Alejandro Forner

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing radiology reporting with large language models: Is GPT-4 the LI-RADS game changer or just a wild card?
Álvaro Díaz-González, Alejandro Forner, Juan Turnes

Liver Int· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional therapies for cholangiocarcinoma: Where they stand?
Ángeles García-Criado, Alexandre Soler, Ezequiel Mauro, Alejandro Forner

Liver Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies.
Mar Ros-Buxó, Ezequiel Mauro, Tamara Sauri, Gemma Iserte, Carla Fuster-Anglada, Alejandro Forner

Curr Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis.
Ezequiel Mauro, Marco Sanduzzi-Zamparelli, Tamara Sauri, Alexandre Soler, Gemma Iserte, Alejandro Forner

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.
Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner

Ann Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide.
Sara Ortiz-Rivero, Ana Peleteiro-Vigil, Lorena Abete, Elisa Lozano, Helen S Hammer, Alejandro Forner

Biomed Pharmacother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.
Julien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, Pascale Maille, Loetitia Favre, Alejandro Forner

Nat Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of the updated Steatotic liver disease nomenclature and definition.
Luca Valenti, Alessio Aghemo, Alejandro Forner, Salvatore Petta, Stefano Romeo

Liver Int· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in biliary tract cancer: The race has begun!
Ezequiel Mauro, Alejandro Forner

Liver Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.
Sergio Muñoz-Martínez, Victor Sapena, Ángeles García-Criado, Anna Darnell, Alejandro Forner

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis